SereVent Diskus · DIN 02231129 · 50 mcg · dry-powder inhaler, 60 doses
Limited Use, Reason for Use code 132, 391 requiredMarketed · checked November 19, 2026
StatusLimited Use, Reason for Use code 132, 391 required
Write on scriptone applicable Reason for Use code, 132 or 391 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 132, 391
Reason for Use code 132
For the treatment of asthma in patients who are using optimum anti-inflammatory treatment and are still experiencing breakthrough symptoms.
Coverage limit:
This drug is not for relief of acute symptoms.
Coverage limit:
LU Authorization Period: Indefinite
Reason for Use code 391
For patients with moderate to severe COPD with persistent respiratory symptoms despite an adequate trial of, or an intolerance to, a regularly scheduled short-acting bronchodilator AND a long-acting anticholinergic.
Coverage limit:
LU Authorization Period: Indefinite
No interchangeable product listed in the Ontario extract
SereVent Diskus · DIN 02231129
Manufacturer: GlaxoSmithKline Inc., GlaxoSmithKline Consumer Health Care; listing date 1998-12-31
Health Canada: Marketed since 2003-01-16 · brand SEREVENT DISKUS (50MCG/DOSE) · ATC R03AC12 SALMETEROL · form Powder · route Inhalation · ingredients SALMETEROL (SALMETEROL XINAFOATE) 50 MCG/ACT · company Glaxosmithkline inc · schedule Prescription
SereVent Diskus: Formulary list price $81.07 per unit (the source does not state the unit; exact figure $81.0700). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02231129)
Source record
DIN 02231129: SereVent Diskus
Raw flags: sec12=Y, sec3=Y
Item: 121200077; group id 236; item number 0418; lccId 00043; manufacturer id GSK
Source form: Pd Inh-60 Dose Pk; strength: 50mcg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $81.0700; ministry $81.0700
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02231129
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=50436
Shortage status: not checked (no credentials)